drugset / Trial / NCT07323680

Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects

NCT07323680

Phase 1 Completed 40 enrolled Rhoshan Pharmaceuticals Inc
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.

Timeline

Start
2025-06-15
Primary completion
2025-07-07
Completion
2025-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 325 mg Oral

Indications

No indication recorded.